• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性口腔黏膜黑色素瘤的临床病理及免疫组织化学分析

A clinicopathological and immunohistochemical analysis of primary oral mucosal melanoma.

作者信息

Barrett A W, Bennett J H, Speight P M

机构信息

Joint Department of Oral Pathology, Eastman Dental Institute, London, UK.

出版信息

Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):100-5. doi: 10.1016/0964-1955(94)00036-4.

DOI:10.1016/0964-1955(94)00036-4
PMID:7633281
Abstract

Nine cases of primary oral mucosal melanoma in Caucasian patients were reviewed and the tumours analysed for expression of S100, HMB45, NKI/C3, HLA-DR, PCNA, cytokeratin and von Willebrand factor. The clinical, histopathological and immunohistochemical features were quite distinctive and our findings support previous suggestions that oral melanoma should be classified as a separate entity rather than as a sub-type of cutaneous melanoma.

摘要

对9例白种人原发性口腔黏膜黑色素瘤患者进行了回顾性研究,并分析了肿瘤中S100、HMB45、NKI/C3、HLA-DR、PCNA、细胞角蛋白和血管性血友病因子的表达情况。其临床、组织病理学和免疫组化特征颇为独特,我们的研究结果支持先前的观点,即口腔黑色素瘤应归类为一个独立的实体,而非皮肤黑色素瘤的一个亚型。

相似文献

1
A clinicopathological and immunohistochemical analysis of primary oral mucosal melanoma.原发性口腔黏膜黑色素瘤的临床病理及免疫组织化学分析
Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):100-5. doi: 10.1016/0964-1955(94)00036-4.
2
The immunohistochemical identification of human oral mucosal melanocytes.人口腔黏膜黑素细胞的免疫组织化学鉴定
Arch Oral Biol. 1997 Jan;42(1):77-81. doi: 10.1016/s0003-9969(96)00113-6.
3
Malignant melanoma of the oral mucosa in a 17-year-old adolescent girl.
Arch Pathol Lab Med. 2002 Sep;126(9):1110-3. doi: 10.5858/2002-126-1110-MMOTOM.
4
Immunohistochemical characterization of experimental Greene melanoma.
Ophthalmic Res. 1992;24(1):55-8. doi: 10.1159/000267146.
5
Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.口腔和鼻窦黏膜恶性黑色素瘤中黑素细胞分化标志物的表达
Am J Surg Pathol. 2001 Jun;25(6):782-7. doi: 10.1097/00000478-200106000-00010.
6
Oral melanoacanthoma: a report of 10 cases, review of the literature, and immunohistochemical analysis for HMB-45 reactivity.
Am J Dermatopathol. 2003 Feb;25(1):12-5. doi: 10.1097/00000372-200302000-00003.
7
Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
J Oral Pathol Med. 1991 Oct;20(9):429-32. doi: 10.1111/j.1600-0714.1991.tb00433.x.
8
Neurotized nevi of the oral mucosa: an immunohistochemical and ultrastructural analysis of nevic corpuscles.
J Oral Pathol Med. 2007 Sep;36(8):505-10. doi: 10.1111/j.1600-0714.2007.00566.x.
9
Establishment and characterization of an oral melanoma cell line (ME).
Oral Oncol. 2001 Apr;37(3):301-7. doi: 10.1016/s1368-8375(00)00116-0.
10
Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.转移性葡萄膜黑色素瘤。形态学和免疫组织化学分析。
Cancer. 1996 Nov 1;78(9):1967-71. doi: 10.1002/(sici)1097-0142(19961101)78:9<1967::aid-cncr18>3.0.co;2-w.

引用本文的文献

1
Primary Malignant Melanoma of Tongue: Rare and Aggressive Malignant Tumor.舌原发性恶性黑色素瘤:罕见且侵袭性强的恶性肿瘤。
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3586-3591. doi: 10.1007/s12070-024-04624-9. Epub 2024 Mar 30.
2
Pevonedistat targeted therapy inhibits canine melanoma cell growth through induction of DNA re-replication and senescence.培维酮司他靶向治疗通过诱导 DNA 再复制和衰老抑制犬黑色素瘤细胞生长。
Vet Comp Oncol. 2020 Sep;18(3):269-280. doi: 10.1111/vco.12546. Epub 2019 Oct 30.
3
A rare case of amelanotic malignant melanoma in the oral region: Clinical investigation and immunohistochemical study.
口腔区域无色素性恶性黑色素瘤1例罕见病例:临床研究与免疫组织化学分析
Oncol Lett. 2015 Dec;10(6):3761-3764. doi: 10.3892/ol.2015.3819. Epub 2015 Oct 20.
4
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.表达异种gp100的同种异体全细胞肿瘤疫苗的研发及其在犬恶性黑色素瘤患者II期临床试验中的应用。
Cancer Immunol Immunother. 2006 Apr;55(4):433-42. doi: 10.1007/s00262-005-0025-6. Epub 2005 Jun 18.